The series of spin rides is a fundraiser for Memorial Sloane Cancer Center, which specializes in the treatment and diagnosis ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy.

In this issue of The Lancet Diabetes & Endocrinology, Michelle M Chen and colleagues1 report their findings on trends in the incidence of thyroid cancer in the USA from 1975 to 2019. The authors show ...

The data she presented also shows that the survival rate for cervical, breast, prostate, and thyroid cancer in Korea ranges ...

I watched my doctor, wondering how he was going to break the news to me – news that would change my life and shake the world ...

Despite efforts to curb overdiagnosis of thyroid cancer, the issue has continued to plague U.S. healthcare, according to results from a retrospective, population-based study.

The highest 5-year survival rates for cancers diagnosed during 2014-2020 were observed for thyroid cancer (98% ... and improvements in treatment. This report also includes projections on new cancer ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

The combination of Opdivo and Yervoy is supported by updated results as a standard of care for MSI-H or dMMR metastatic ...